Actimed Therapeutics Ltd., of Berkshire, U.K., appointed Annalisa Jenkins advisor.
Biocryst Pharmaceuticals Inc., of Research Triangle Park, N.C., appointed Anthony Doyle senior vice president and chief financial officer.
Curevac AG, of Tubingen, Germany, appointed Jean Stéphenne chair of its board.
E-therapeutics plc, of Oxford, U.K., appointed Laura Roca-Alonso chief business officer.
Galera Therapeutics Inc., of Malvern, Pa., appointed Linda B. West to its board.
Insmed Inc., of Bridgewater, N.J., appointed Carol A. Schafer to its board.
Oric Pharmaceuticals Inc., of South San Francisco, appointed Christian V. Kuhlen general counsel.
Replimune Group Inc., of Woburn, Mass., appointed Dieter Weinand chair of its board. It also named Paolo Pucci to the board.
Stridebio Inc., of Research Triangle Park, N.C., appointed Maritza McIntyre chief development officer.